Current challenges in TAVI: neo-commissural alignment to mimic more physiologic valve implantation

Abstract

Commissural alignment during transcatheter aortic valve implantation (TAVI) has important clinical implications as TAVI expands to younger patients in whom lifetime treatment of aortic valve disease and coronary artery disease is of particular importance. Numerous studies have shown that lack of commissural alignment may adversely affect coronary reaccess and the feasibility of redo-TAVI in this patient population. To assess the risk of commissural misalignment more accurately, we have pioneered and validated the use of a preprocedural imaging protocol that determines valve orientation using multi-detector computed tomography-fluoroscopy co-registration. Furthermore, we have shown that a modified delivery system insertion technique during initial valve deployment results in improved commissural alignment and reduced coronary artery overlap following TAVI with a self-expanding device. However, numerous unanswered questions remain about the impact of commissural misalignment on balloon-expandable valve-in-valve TAVI, especially in patients with unfavorable aortic root anatomy. It is imperative that clinicians consider these anatomic, device-related, and procedure factors, among others, when evaluating patients for transcatheter therapies.

Keywords

Aortic stenosis / commissural alignment / aortic valve / coronary artery disease

References

[1] Mack MJ,Thourani VH.Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients..N Engl J Med2019;380:1695-705

[2] Popma JJ,Yakubov SJ.Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients..N Engl J Med2019;380:1706-15

[3] Fuchs A,Yoon SH.Commissural alignment of bioprosthetic aortic valve and native aortic valve following surgical and transcatheter aortic valve replacement and its impact on valvular function and coronary filling..JACC Cardiovasc Interv2018;11:1733-43

[4] Buzzatti N,De Backer O.Coronary access after repeated transcatheter aortic valve implantation: a glimpse into the future..JACC Cardiovasc Imaging2020;13:508-15

[5] Tang GHL,Ahmad H,Lansman SL.Transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement..Circ Cardiovasc Interv2018;11:e007263

[6] Gunning PS,McNamara LM.Simulation of self expanding transcatheter aortic valve in a realistic aortic root: implications of deployment geometry on leaflet deformation..Ann Biomed Eng2014;42:1989-2001

[7] Tang GHL,Cavalcante JL.Predicting the feasibility of post-TAVR coronary access and redo TAVR: more unknowns than knowns..JACC Cardiovasc Interv2020;13:736-8

[8] Webb JG,Alu MC.3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses: the PARTNER 2 registry..J Am Coll Cardiol2019;73:2647-55

[9] Lederman RJ,Rogers T.Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA..JACC Cardiovasc Interv2019;12:1197-216 PMCID:PMC6724191

[10] Tang GHL,Gupta E.Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess..Circ Cardiovasc Interv2019;12:e008044

[11] Alexis SL,Sengupta A.Transcatheter aortic valve replacement aortic root orientation: implications for future coronary access and redo transcatheter aortic valve replacement..Ann Cardiothorac Surg2020;

[12] Tang GHL,Fuchs A.Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap..JACC Cardiovasc Interv2020;13:1030-42

[13] Yudi MB,Tang GHL.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement..J Am Coll Cardiol2018;71:1360-78

[14] Figulla HR,Lauten A.The transcatheter valve technology pipeline for treatment of adult valvular heart disease..Eur Heart J2016;37:2226-39

[15] Rogers T,Weissman G.Feasibility of coronary access and aortic valve reintervention in low-risk TAVR patients..JACC Cardiovasc Interv2020;13:726-35

[16] Tang GHL,Gupta E.Feasibility of repeat TAVR after SAPIEN 3 TAVR: a novel classification scheme and pilot angiographic study..JACC Cardiovasc Interv2019;12:1290-2

[17] Tang GHL,Sengupta A.Commissural alignment in evolut TAVR: results from the low risk LTI sub-study..J Am Coll Cardiol2020;76:B41